Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
View ORCID ProfileLaith J. Abu Raddad, View ORCID ProfileHiam Chemaitelly, View ORCID ProfileHoussein H. Ayoub, View ORCID ProfileZaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, View ORCID ProfileAdeel A. Butt, Peter Coyle, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Robert C. Owen, View ORCID ProfileHanan F. Abdul Rahim, Samya A. Al Abdulla, Mohamed G. Al Kuwari, Mujeeb C. Kandy, Hatoun Saeb, Shazia Nadeem N. Ahmed, Hamad Eid Al Romaihi, Devendra Bansal, Louise Dalton, Sheikh Mohammad Al Thani, Roberto Bertollini
doi: https://doi.org/10.1101/2020.07.16.20155317
Laith J. Abu Raddad
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
3Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
PhDHiam Chemaitelly
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
MScHoussein H. Ayoub
4Department of MAthematics, Statistics, and Physics, Qatar University, Doha, Qatar
PhDZaina Al Kanaani
5Hamad Medical Corporation, Doha, Qatar
PhDAbdullatif Al Khal
5Hamad Medical Corporation, Doha, Qatar
MDEinas Al Kuwari
5Hamad Medical Corporation, Doha, Qatar
MDAdeel A. Butt
5Hamad Medical Corporation, Doha, Qatar
MDPeter Coyle
5Hamad Medical Corporation, Doha, Qatar
MDAndrew Jeremijenko
5Hamad Medical Corporation, Doha, Qatar
MDAnvar Hassan Kaleeckal
5Hamad Medical Corporation, Doha, Qatar
MScAli Nizar Latif
5Hamad Medical Corporation, Doha, Qatar
MDRobert C. Owen
5Hamad Medical Corporation, Doha, Qatar
MDHanan F. Abdul Rahim
6College of Health Sciences, QU Health, Qatar University, Doha, Qatar
PhDSamya A. Al Abdulla
7Primary Health Care Corporation, Doha, Qatar
MDMohamed G. Al Kuwari
7Primary Health Care Corporation, Doha, Qatar
MDMujeeb C. Kandy
7Primary Health Care Corporation, Doha, Qatar
MScHatoun Saeb
7Primary Health Care Corporation, Doha, Qatar
MScShazia Nadeem N. Ahmed
8Ministry of Public Health, Doha, Qatar
MDHamad Eid Al Romaihi
8Ministry of Public Health, Doha, Qatar
MDDevendra Bansal
8Ministry of Public Health, Doha, Qatar
PhDLouise Dalton
8Ministry of Public Health, Doha, Qatar
MASheikh Mohammad Al Thani
8Ministry of Public Health, Doha, Qatar
MDRoberto Bertollini
8Ministry of Public Health, Doha, Qatar
MDData Availability
Data are available at the discretionary of stakeholders.
Posted July 28, 2020.
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Laith J. Abu Raddad, Hiam Chemaitelly, Houssein H. Ayoub, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Adeel A. Butt, Peter Coyle, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Robert C. Owen, Hanan F. Abdul Rahim, Samya A. Al Abdulla, Mohamed G. Al Kuwari, Mujeeb C. Kandy, Hatoun Saeb, Shazia Nadeem N. Ahmed, Hamad Eid Al Romaihi, Devendra Bansal, Louise Dalton, Sheikh Mohammad Al Thani, Roberto Bertollini
medRxiv 2020.07.16.20155317; doi: https://doi.org/10.1101/2020.07.16.20155317
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Laith J. Abu Raddad, Hiam Chemaitelly, Houssein H. Ayoub, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Adeel A. Butt, Peter Coyle, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Robert C. Owen, Hanan F. Abdul Rahim, Samya A. Al Abdulla, Mohamed G. Al Kuwari, Mujeeb C. Kandy, Hatoun Saeb, Shazia Nadeem N. Ahmed, Hamad Eid Al Romaihi, Devendra Bansal, Louise Dalton, Sheikh Mohammad Al Thani, Roberto Bertollini
medRxiv 2020.07.16.20155317; doi: https://doi.org/10.1101/2020.07.16.20155317
Subject Area
Subject Areas
- Addiction Medicine (372)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2760)
- Dermatology (236)
- Emergency Medicine (414)
- Epidemiology (12413)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4272)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2761)
- Health Policy (1021)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (454)
- Neurology (4054)
- Nursing (218)
- Nutrition (600)
- Oncology (2134)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1150)
- Primary Care Research (470)
- Public and Global Health (6663)
- Radiology and Imaging (1452)
- Respiratory Medicine (886)
- Rheumatology (422)
- Sports Medicine (353)
- Surgery (465)
- Toxicology (57)
- Transplantation (192)
- Urology (171)